Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121509552 | 12150955 | 2 | F | 2012 | 20160425 | 20160304 | 20160909 | PER | US-ASTRAZENECA-2012BM06276 | ASTRAZENECA | 70.00 | YR | F | Y | 81.20000 | KG | 20160909 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121509552 | 12150955 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | 21773 | 5 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||||||
| 121509552 | 12150955 | 2 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | A869551A | 21773 | 10 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | ||||||
| 121509552 | 12150955 | 3 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | 21773 | 10 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||||||
| 121509552 | 12150955 | 4 | C | GLUCOPHAGE | METFORMIN HYDROCHLORIDE | 1 | Oral | EVERY DAY | 0 | ||||||||||
| 121509552 | 12150955 | 5 | C | GLIPIZIDE. | GLIPIZIDE | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 121509552 | 12150955 | 6 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 0 | 30 | UG | |||||||||
| 121509552 | 12150955 | 7 | C | NEURONTIN | GABAPENTIN | 1 | Oral | 0 | 100 | MG | QD | ||||||||
| 121509552 | 12150955 | 8 | C | PAROXETINE HCL | PAROXETINE HYDROCHLORIDE | 1 | Oral | 0 | 30 | MG | QD | ||||||||
| 121509552 | 12150955 | 9 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Oral | 0 | 150 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121509552 | 12150955 | 1 | Type 2 diabetes mellitus |
| 121509552 | 12150955 | 2 | Type 2 diabetes mellitus |
| 121509552 | 12150955 | 3 | Type 2 diabetes mellitus |
| 121509552 | 12150955 | 4 | Type 2 diabetes mellitus |
| 121509552 | 12150955 | 5 | Type 2 diabetes mellitus |
| 121509552 | 12150955 | 7 | Feeling abnormal |
| 121509552 | 12150955 | 8 | Depression |
| 121509552 | 12150955 | 9 | Depression |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121509552 | 12150955 | Asthenopia | |
| 121509552 | 12150955 | Bronchitis | |
| 121509552 | 12150955 | Dry mouth | |
| 121509552 | 12150955 | Injection site pain | |
| 121509552 | 12150955 | Injection site pruritus | |
| 121509552 | 12150955 | Injection site urticaria | |
| 121509552 | 12150955 | Product quality issue | |
| 121509552 | 12150955 | Underdose | |
| 121509552 | 12150955 | Urine output increased | |
| 121509552 | 12150955 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121509552 | 12150955 | 3 | 20160118 | 0 |